Skip to main content
Erschienen in: Italian Journal of Pediatrics 1/2024

Open Access 01.12.2024 | Case report

Multidisciplinary follow-up in a patient with Morgagni hernia leads to diagnosis of Marfan syndrome

verfasst von: Ester Capecchi, Roberta Villa, Alessandro Pini, Maria Iascone, Laura Messina, Paola Francesca Ajmone, Fabio Mosca, Silvana Gangi, Maria Francesca Bedeschi

Erschienen in: Italian Journal of Pediatrics | Ausgabe 1/2024

Abstract

Background

congenital diaphragmatic hernia (CDH) is a birth defect occurring in isolated or syndromic (chromosomal or monogenic) conditions. The diaphragmatic defect can be the most common one: left-sided posterolateral, named Bochdalek hernia; or it can be an anterior-retrosternal defect, named Morgagni hernia. Marfan syndrome (MFS) is a rare autosomal dominant inherited condition that affects connective tissue, caused by mutations in fibrillin-1 gene on chromosome 15. To date various types of diaphragmatic defects (about 30 types) have been reported in association with MFS, but they are heterogeneous, including CDH and paraesophageal hernia.

Case presentation

We describe the case of a child incidentally diagnosed with Morgagni hernia through a chest X-ray performed due to recurrent respiratory tract infections. Since the diagnosis of CDH, the patient underwent a clinical multidisciplinary follow-up leading to the diagnosis of MFS in accordance with revised Ghent Criteria: the child had typical clinical features and a novel heterozygous de novo single-base deletion in exon 26 of the FBN1 gene, identified by Whole-Exome Sequencing. MFS diagnosis permitted to look for cardiovascular complications and treat them, though asymptomatic, in order to prevent major cardiovascular life-threatening events.

Conclusion

Our case shows the importance of a long-term and multidisciplinary follow-up in all children with diagnosis of CDH.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Congenital diaphragmatic hernia (CDH) is a relatively common major birth defect with estimated incidence between 1/2.000 and 1/3.000 live- and still-births [13]. Left-sided posterolateral diaphragmatic defects, named Bochdalek hernias (BH) are the most common and occur in 85% of all cases, followed by anterior-retrosternal defects, named Morgagni hernias (MH) [4]. BH is usually diagnosed in the prenatal period on ultrasound or soon after birth in a newborn with severe respiratory distress due to pulmonary hypoplasia [3, 4]. MH occurs more often on the right hemidiaphragm and is usually incidentally diagnosed in adulthood because of its asymptomatic course. When symptoms occur they include respiratory complaints or gastrointestinal symptoms [4, 5].
Approximately 40 to 50% of cases of CDH occur in combination with additional congenital abnormalities (complex CDH), such as congenital heart diseases, either as a part of a syndrome or a non-syndromic association [1, 3]. The frequency of syndromic forms of CDH ranges from 14 to 44% [1] including chromosomal defects and monogenic conditions [6].
Marfan syndrome (OMIM #154,700, MFS) is among the monogenic conditions with CDH as described features.
MFS is a rare (reported incidence of one in 5.000–10.000 births) autosomal dominant inherited condition that affects connective tissue, caused by mutations in fibrillin-1 (FBN1, OMIM*13,479) gene on chromosome 15. Fibrillin-1 is the main protein component of extracellular microfibrils that are thought to contribute to the formation and maintenance of elastic fibres.
Cardinal features of MFS involve the skeletal, cardiovascular and ocular systems; the signs and symptoms of MFS can vary greatly, even among members of the same family [710]. Clinical diagnosis is based on the 2010 revised Ghent criteria, which replaces the previous 1996 nosology arising from the 1988 revision of the Berlin diagnostic criteria [7]..
Various types of CDH have been reported in association with MFS, especially in the early onset MFS or neonatal form (nMFS) [11]. MH appear to be a rarer entity associated to MFS reported to date in only 5 cases (2 children and 3 adults) [1115]. Herein, we describe an additional case of a 5-years-old-boy diagnosed with MH carrying a novel de novo pathogenic variant in FBN1.
.

Case presentation

Our patient was an Italian male born at term by spontaneous delivery, after uncomplicated pregnancy. The baby was the first child of non-consanguineous parents. The mother was 32 years old and was on L-thyroxine replacement therapy for hypothyroidism due to Hashimoto’s thyroiditis. The father (35years old) was in good health and had another healthy son. The family history was remarkable for a paternal uncle, dead at birth because of bilateral renal agenesis, and a paternal aunt born deaf because of cochlear agenesis. At birth, the weight was 3.530 g (64th percentile), the length was 50 cm (52nd percentile) and the head circumference was 36 cm (92nd percentile). Apgar score was 10 at 1st and 5th minute. The child had physiologic perinatal period and normal psychomotor development.
During the first year of life, he presented recurrent respiratory tract infections.
At 16 months of age, due to slowly-resolving bronchopneumonia diagnosed 15 days earlier, he presented to the Emergency Department where he performed a chest X-ray revealing the presence of intestinal loops in the mediastinum, suggesting a diaphragmatic hernia. The child was then referred to our Surgical Department where, a computed tomography scan of the chest confirmed the anterior herniation of the diaphragm (MH). The cardiologic evaluation and the abdominal echography were normal. A genetic evaluation showed minor facial anomalies such as downlanting palpebral fissure, epichantal folds, protruding ears, malar hypoplasia, full lip, retrognathia, ogival palate, pectus carinatum, clinodactyly of the 5th finger, slight hypermobility of distal interphalangeal joints, normal development milestones and anthropometric parameters with height at 75-90th percentile. A specific pattern of syndrome was not recognized. An array-CGH (Array-Comparative Genomic Hybridization) (8 × 60 K Kit) was unremarkable. The patient underwent surgical repair through laparoscopic transabdominal route which was followed by substantially uneventful recovery.
After the discharged, a multidisciplinary follow-up was started to provide the necessary care for the possible CDH-complications.
Over the next months, he was diagnosed with bilateral flat and valgus feet, corrected with orthopedic insoles, and vitamin D deficiency for which supplementation was started. The surgical follow-up was normal; the respiratory function tests resulted concordant with values of children with CDH and the first ophthalmologist visit documented ocular divergence in the upward gaze.
At 32 months of age, the proband and his parents underwent to trio-based whole-exome sequencing (WES). WES identified the frameshift variant NM_000138.4:c.3089del; (p.Asn1030Metfs*5) in exon 26 of FBN1, which was further confirmed by Sanger sequencing. The variant occurred de novo in the proband. It was absent in population databases (i.e. gnomAD) and is predicted as disease causing by several bioinformatics tools, consistent with the early termination of protein translation. According to the ACMG/AMP guidelines, NM_000138.4:c.3089del would be classified as pathogenic based on the criteria involving PVS1, PM2, PM6 and PP5. At 38 months of age, the transthoracic echocardiography showed ectasia of the aortic root to the sinuses of Valsalva (Z-score 2,35) with normal aortic valve, mitral valve prolapse (MVP) with mild regurgitation and initially thickened flaps. An angiotensin converting enzyme (ACE) inhibitor was prescribed to the child in order to regularize the growth rate of the aortic root and reduce the ratio between aortic root and body surface over time. Moreover, the ophthalmologic examination was normal. In accordance with revised Ghent Criteria MFS diagnosis was established in the patient. The last genetic evaluation at 5 year-old confirmed minor facial and skeletal anomalies  , marfanoid habitus, slight hypermobility of distal interphalangeal joints and normal psychomotor development (Figure 1).

Discussion and conclusions

MFS is a multiorgan disorder affecting eyes, skeleton, heart and arteries, dura and lungs; it is notable for its phenotypic variability in age at onset, organ involved and severity of clinical manifestation, both among and within affected families.
MFS is diagnosed according to the revised Ghent criteria. In 2010 the Ghent Criteria were updated adding genetic testing of FBN1 and the presence of a causative FBN1 variant as key criteria in the diagnosis of MFS besides major clinical features as aortic root dilatation and ectopia lentis [10].
Though the use of revised Ghent Criteria improves the diagnostic yield of MFS, in young children the diagnosing MFS is still very challenging as some of its clinical manifestations are age dependent.
Our patient satisfies the criteria showing aortic root dilatation and causal mutation of FBN1 gene. He also presents a Systemic Score of 3: plain flat foot (1 points); peculiar facial anomalies with dolichocephaly, down-slanting palpebral fissures, malar hypoplasia and retrognathia (1 point) and MVP (1 point). Moreover, arachnodactyly is evident in both hands and feet.
Aortic root dilatation, initially occurring at the sinuses of Valsalva, is the main cardiovascular manifestation of MFS, which can lead to life-threatening sequelae (i.e. aortic dissection).
The reported prevalence in young children with MFS varies among studies from 50 to 83% and increase with time. Aburawi et al. estimated an aortic root dilatation prevalence of 35% at 5 years [16]. In our patient, aortic dilatation was described at 3 years of age, while the previous echocardiography at 16 months of life was normal.
In our report, WES analysis revealed a de novo heterozygous single-base deletion in in exon 26 of FBN1 gene ( NM_000138.4:c.3089del) producing an altered reading frame and generating a premature termination of translation. The mutation appears to be novel; nevertheless, according to the current ACMG/AMP guideline it is possible to definite it causative.
To date, few genotype-phenotype correlations for FBN1 mutations have been uncovered. In a series of 570 adult patient with MFS, those with FBN1 haploinsufficiency mutations had a significantly increased risk for any aortic complications (such as aortic dissection, aortic surgery) than those with missense (dominant-negative) mutations (adjusted hazard ratio 1.6; 95%CI 1.1–2.7) [17]. In addition, Baudhuin L. M. et al. found that the ratio of FBN1 truncation mutations was also higher in the aortic events in patients affected by MFS [18]. It is also reported in some previous studies that patients harbouring truncating mutation show lower likelihood of diagnosis of ectopia lentis versus patients with missense mutations [19]. This data supports the absence of any actual ocular manifestations in our patient.
Variants in exons 24–32 are typically associated with a severe form of MFS rapidly progressive [], previously named nMFS [9]. However, some patients with severe MFS lack mutations in this region and many patients with mutations in this region have classic or mild variants of MFS. Likewise, we identified in our proband a FBN1 pathogenic variant in exon 26 which seems to have a little prognostic value as our patient presents a mild phenotype of MFS.
Although gastrointestinal tract manifestations are not listed in Ghent nosology as a diagnostic sign of MFS, many MFS patients’ present gastrointestinal tract involvement such as liver cysts, biliary duct ectasia, CDH, intussusception, volvulus, as well as functional disorders.
To the best of our knowledge 24 cases of CDH associated with MFS have been reported so far and listed in Table 1. The definitive pathogenetic explanation for the association of CDH and MFS is still limited. However, it is thought that diaphragmatic defect is caused by a deficiency of fibrillin-1 during fetal development of diaphragm that may disrupt mesenchymal cell proliferation, causing malformed muscle tissue as well as abnormally lax oesophageal hiatus and lax gastric ligamentous attachments resulting in diaphragmatic defects, as was documented in the foetuses of rats nitrofen-induced CDH model [20].
Table 1
Defect of the diaphragm and FBN1 mutation
 
Article
FBN1
Mutation
Family history
Age at CDH diagnosis
Type of CDH
1
Parida et al., 1997 [26]
n.a.
positive
birth
PHE
2
Jacobs et al., 2002 [27]
c.3143T > C
negative
birth
Right-BH
3
Yetman et al., 2003 [13]
n.a.
n.a.
22 years
Right-MH
4
Peterson et al., 2003; case 1 [28]
n.a.
positive
20 days
PHE
5
Peterson et al., 2003; case 2 [28]
n.a.
positive
birth
PHE
6
Peterson et al., 2003; case 2 mother [28]
n.a.
n.a.
3 months
PHE
7
Al-Assiri et al., 2005 [29]
n.a.
positive
prenatal
PHE
8
Barakat et al., 2005 [30]
n.a.
positive
43 years
Right hemidiaphragm agenesia
9
Keswani et al., 2007 [31]
n.a.
positive
35 years
PHE
10
Jetley et al., 2009; case 3 [32]
n.a.
positive
4 months
PHE
11
Jetley et al., 2009; case 8 [32]
n.a.
positive
birth
PHE
12
Martinez-Lesquerux et al., 2010 [14]
n.a.
n.a.
53 years
Left-MH
13
Ayse Esin et al., 2010 [4]
n.a.
positive
9 years
Right-MH
14
Herman et al., 2013 [33]
n.a.
positive
birth
PHE
15
Thakur et al., 2017 [34]
n.a.
negative
25 years
PHE
16
Beck et al., 2015; father [2]
c.4969_4970insA
n.a.
10 years
PHE
17
Beck et al., 2015; son [2]
c.4969_4970insA
positive
2 months
Right-BH
18
Laumonerie et al., 2015 [12]
c.733 C > T
positive
2 months
MH
19
Stępiński et al., 2016 [35]
n.a.
n.a.
26 years
PHE
20
Kothari et al., 2017 [36]
n.a.
n.a.
35 years
PHE
21
S. Somasundaram et al., 2019
[15]
n.a.
n.a.
45 years
MH
22
Gupta et al., 2020; sibling 1 [37]
n.a.
positive
< 3 years
PHE
23
Gupta et al., 2020; sibling 2 [37]
n.a.
positive
< 3 years
PHE
24
Hou et al., 2021 [38]
n.a.
n.a.
77 years
PHE
25
Present case
c.3089del
Negative
16 months
MH
FBN1: fibrillin-1 gene; n.a.: not available; CDH: congenital diaphragmatic hernia; PHE: paraesophageal hernia; BH: Bochdalek hernia; MH: Morgagni hernia
As showed in Table 1, PHE is the most common type of diaphragmatic defects reported in patients with MFS. The CDH doesn’t seem to be associated with a specific MFS phenotype. In our case the patient had a MH, of which only 5 cases in association with MFS were previously described. The age of MH diagnoses ranging from 2 month to 53 years with a median age of 22 years as the majority of patients tend to be pauci- or a-symptomatic.
Yetman et al. reported a MH in a 22-year-old man with MFS presented with acute dyspnea secondary to bowel herniation, who, similarly to our case, was initially incorrectly diagnosticated as an acute pneumonia. Later, the diagnosis of MFS in this patient was stated as the presence of aortic root dilatation, mitral valve prolapse, ocular lens subluxation and skeletal anomalies [13]. Similarly, Ayse Esin et al. described the diagnosis of MH in a 9-year-old female presenting with respiratory symptoms. a positive family history of MFS and, at physical examination, MFS facial appearance, tall stature and a systolic murmur that prompts the diagnosis of aortic root dilatation and mitral and tricuspid valve prolapse[4]. Laumonerie et al. described a 3 month-old female with phenotype and family history strongly suggestive for MFS presenting with MH [12]. This case demonstrates an affinity with our report as MH was the first feature of MFS and the infant showed cardiac involvement requiring for targeted therapy already at a young age.
According to cardiological involvement showed in some cases, we cannot say that patients with MFS and MH have less severe clinical phenotype; rather we highlight how an early diagnosis of MFS is essential to prevent cardiovascular complications, in order to increase life expectancy of patients [21].
MFS prognosis is related to aortic root dissection, a complication related to aortic root dilatation. A French multicentre study assessed the incidence of cardiovascular events and their associated risk markers in children with MFS and set that a close follow up and timely prophylactic surgery during childhood prevent dissection and that aortic root Z score and aortic valve regurgitation seem interesting risk markers for cardiovascular events and progressive aortic root dilation [22].
In our case, the child has aortic root dilatation and mitral valve prolapse at the age of 4 years and a prophylactic treatment was started.
Traditionally B-blockers and angiotensin receptor blockers (ARBs) are prescribed at the time of diagnosis with MFS at any age or upon appreciation of progressive aortic dilatation. These drugs are expected to reduce the risk of aortic dissection reducing the systolic ejection impulse and consequently hemodynamic stress on the aortic wall [7]. Chiu et al. demonstrated that the combination of B-blockers and losartan affords better protection against aortic root enlargement than B-blockers alone in children with MFS [23]. In the same yeara study conducted in a small cohort of young patients with MFS proved a significant improvement with losartan monotherapy in all affected proximal aortic segments, with a better response to therapy when started at an earlier age and with a longer therapy duration [24].
As alternative to B-blockers and ARBs, calcium antagonists and ACE inhibitors have been considered. Enalapril has been seen to improve aortic distensibility and reduce the rate of aortic dilatation compared with B-blockers in a small not randomized clinical trial in children and adolescents [25]. According to these findings Enalapril therapy was started in our case.
Our experience teaches the importance of a multidisciplinary follow up, particularly genetic and pediatric one, for a child with an occasional anterior CDH and some minor dysmorphisms. The continuous clinical evaluations of the patient allowed to make diagnosis and to set up an early cardiological therapy in an asymptomatic child that we hope will prevent the even fatal complications of MFS.

Acknowledgements

This work has been generated within the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA) (EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516).

Declarations

Not applicable.
A written and signed consent was obtained from both parents prior to submission.

Competing interests

The authors declare that they have no financial or other relationships that might lead to a conflict of interest.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Slavotinek AM. Single gene disorders associated with congenital diaphragmatic hernia. Am J Med Genet. 2007;145 C:172–83.CrossRefPubMed Slavotinek AM. Single gene disorders associated with congenital diaphragmatic hernia. Am J Med Genet. 2007;145 C:172–83.CrossRefPubMed
2.
Zurück zum Zitat Beck TF, Campeau PM, Jhangiani SN, Gambin T, Li AH, Abo-Zahrah R, et al. FBN1 contributing to familial congenital diaphragmatic hernia: FBN1 CDH. Am J Med Genet. 2015;167:831–6.CrossRef Beck TF, Campeau PM, Jhangiani SN, Gambin T, Li AH, Abo-Zahrah R, et al. FBN1 contributing to familial congenital diaphragmatic hernia: FBN1 CDH. Am J Med Genet. 2015;167:831–6.CrossRef
3.
Zurück zum Zitat van den Hout L, Sluiter I, Gischler S, De Klein A, Rottier R, Ijsselstijn H, et al. Can we improve outcome of congenital diaphragmatic hernia? Pediatr Surg Int. 2009;25:733–43.CrossRefPubMedPubMedCentral van den Hout L, Sluiter I, Gischler S, De Klein A, Rottier R, Ijsselstijn H, et al. Can we improve outcome of congenital diaphragmatic hernia? Pediatr Surg Int. 2009;25:733–43.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Ayse Esin K, Bahar C, Fatih A, Tugrul T, Nur P, Ozleml K. Delayed presentation of Morgagni hernia in a patient with Marfan syndrome. Pediatr Int. 2010;52:e17–9.CrossRefPubMed Ayse Esin K, Bahar C, Fatih A, Tugrul T, Nur P, Ozleml K. Delayed presentation of Morgagni hernia in a patient with Marfan syndrome. Pediatr Int. 2010;52:e17–9.CrossRefPubMed
5.
Zurück zum Zitat Minneci PC, Deans KJ, Kim P, Mathisen DJ. Foramen of Morgagni hernia: changes in diagnosis and treatment. Ann Thorac Surg. 2004;77:1956–9.CrossRefPubMed Minneci PC, Deans KJ, Kim P, Mathisen DJ. Foramen of Morgagni hernia: changes in diagnosis and treatment. Ann Thorac Surg. 2004;77:1956–9.CrossRefPubMed
6.
Zurück zum Zitat Yu L, Hernan RR, Wynn J, Chung WK. The influence of genetics in congenital diaphragmatic hernia. Semin Perinatol. 2020;44:151169.CrossRefPubMed Yu L, Hernan RR, Wynn J, Chung WK. The influence of genetics in congenital diaphragmatic hernia. Semin Perinatol. 2020;44:151169.CrossRefPubMed
7.
Zurück zum Zitat Dean JCS. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet. 2007;15:724–33.CrossRefPubMed Dean JCS. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet. 2007;15:724–33.CrossRefPubMed
8.
Zurück zum Zitat Pepe G, Giusti B, Sticchi E, Abbate R, Gensini G, Nistri S. Marfan syndrome: current perspectives. TACG 2016:55. Pepe G, Giusti B, Sticchi E, Abbate R, Gensini G, Nistri S. Marfan syndrome: current perspectives. TACG 2016:55.
9.
Zurück zum Zitat Veiga-Fernández A, Joigneau Prieto L, Álvarez T, Ruiz Y, Pérez R, Gámez F, et al. Perinatal diagnosis and management of early-onset Marfan syndrome: case report and systematic review. J Maternal-Fetal Neonatal Med. 2020;33:2493–504.CrossRef Veiga-Fernández A, Joigneau Prieto L, Álvarez T, Ruiz Y, Pérez R, Gámez F, et al. Perinatal diagnosis and management of early-onset Marfan syndrome: case report and systematic review. J Maternal-Fetal Neonatal Med. 2020;33:2493–504.CrossRef
10.
Zurück zum Zitat Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476–85.CrossRefPubMed Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476–85.CrossRefPubMed
11.
Zurück zum Zitat von Kodolitsch Y, Demolder A, Girdauskas E, Kaemmerer H, Kornhuber K, Muino Mosquera L, et al. Features of Marfan syndrome not listed in the Ghent nosology– the dark side of the disease. Expert Rev Cardiovasc Ther. 2019;17:883–915.CrossRef von Kodolitsch Y, Demolder A, Girdauskas E, Kaemmerer H, Kornhuber K, Muino Mosquera L, et al. Features of Marfan syndrome not listed in the Ghent nosology– the dark side of the disease. Expert Rev Cardiovasc Ther. 2019;17:883–915.CrossRef
12.
Zurück zum Zitat Laumonerie P, Mouttalib S, Edouard T, Galinier P. Hernie de la fente de larrey chez un nourrisson de trois mois atteint du syndrome de Marfan. Archives de Pédiatrie. 2015;22:1151–3.CrossRefPubMed Laumonerie P, Mouttalib S, Edouard T, Galinier P. Hernie de la fente de larrey chez un nourrisson de trois mois atteint du syndrome de Marfan. Archives de Pédiatrie. 2015;22:1151–3.CrossRefPubMed
13.
Zurück zum Zitat Yetman AT, Greenberg SB, Ghaffar S. Diaphragmatic hernia. Pediatr Cardiol. 2003;1:307–8.CrossRef Yetman AT, Greenberg SB, Ghaffar S. Diaphragmatic hernia. Pediatr Cardiol. 2003;1:307–8.CrossRef
14.
Zurück zum Zitat Martínez-Lesquereux L, Parada-González P, Macías-García F, Beiras-Torrado A. Morgagni-Larrey diaphragmatic hernia as cause of intestinal obstruction in a patient with Marfan’s syndrome. Rev Esp Enferm Dig 2010;102. Martínez-Lesquereux L, Parada-González P, Macías-García F, Beiras-Torrado A. Morgagni-Larrey diaphragmatic hernia as cause of intestinal obstruction in a patient with Marfan’s syndrome. Rev Esp Enferm Dig 2010;102.
15.
Zurück zum Zitat Somasundaram S, Ackermann S, Beenen TG. Laparoscopic repair of a complex Morgagni hernia in a patient with Marfan syndrome. ANZ J Surg. 2019;89:E284–5.CrossRef Somasundaram S, Ackermann S, Beenen TG. Laparoscopic repair of a complex Morgagni hernia in a patient with Marfan syndrome. ANZ J Surg. 2019;89:E284–5.CrossRef
16.
Zurück zum Zitat Aburawi EH, O’Sullivan J. Relation of aortic root dilatation and age in Marfan’s syndrome. Eur Heart J. 2007;28:376–9.CrossRefPubMed Aburawi EH, O’Sullivan J. Relation of aortic root dilatation and age in Marfan’s syndrome. Eur Heart J. 2007;28:376–9.CrossRefPubMed
17.
Zurück zum Zitat Franken R, Groenink M, de Waard V, Feenstra HMA, Scholte AJ, van den Berg MP, et al. Genotype impacts survival in Marfan syndrome. Eur Heart J. 2016;37:3285–90.CrossRefPubMed Franken R, Groenink M, de Waard V, Feenstra HMA, Scholte AJ, van den Berg MP, et al. Genotype impacts survival in Marfan syndrome. Eur Heart J. 2016;37:3285–90.CrossRefPubMed
18.
Zurück zum Zitat Baudhuin LM, Kotzer KE, Lagerstedt SA. Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Sci. 2015;17:177–87. Baudhuin LM, Kotzer KE, Lagerstedt SA. Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Sci. 2015;17:177–87.
19.
Zurück zum Zitat Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan Syndrome or related phenotypes and FBN1 mutations: an International Study. Am J Hum Genet. 2007;81:454–66.CrossRefPubMedPubMedCentral Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan Syndrome or related phenotypes and FBN1 mutations: an International Study. Am J Hum Genet. 2007;81:454–66.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Takahashi T, Friedmacher F, Zimmer J, Puri P. Fibrillin-1 expression is decreased in the diaphragmatic muscle connective tissue of Nitrofen-Induced congenital diaphragmatic hernia. Eur J Pediatr Surg. 2016;27:026–31.CrossRef Takahashi T, Friedmacher F, Zimmer J, Puri P. Fibrillin-1 expression is decreased in the diaphragmatic muscle connective tissue of Nitrofen-Induced congenital diaphragmatic hernia. Eur J Pediatr Surg. 2016;27:026–31.CrossRef
21.
Zurück zum Zitat Pyeritz RE. Marfan syndrome: 30 years of research equals 30 years of additional life expectancy. Heart. 2008;95:173–5.CrossRefPubMed Pyeritz RE. Marfan syndrome: 30 years of research equals 30 years of additional life expectancy. Heart. 2008;95:173–5.CrossRefPubMed
22.
Zurück zum Zitat Hascoet S, Edouard T, Plaisancie J, Arnoult F, Milleron O, Stheneur C, et al. Incidence of cardiovascular events and risk markers in a prospective study of children diagnosed with Marfan syndrome. Arch Cardiovasc Dis. 2020;113:40–9.CrossRefPubMed Hascoet S, Edouard T, Plaisancie J, Arnoult F, Milleron O, Stheneur C, et al. Incidence of cardiovascular events and risk markers in a prospective study of children diagnosed with Marfan syndrome. Arch Cardiovasc Dis. 2020;113:40–9.CrossRefPubMed
23.
Zurück zum Zitat Chiu H-H, Wu M-H, Wang J-K, Lu C-W, Chiu S-N, Chen C-A, et al. Losartan added to β-Blockade therapy for aortic Root Dilation in Marfan Syndrome: a randomized, open-label pilot study. Mayo Clin Proc. 2013;88:271–6.CrossRefPubMed Chiu H-H, Wu M-H, Wang J-K, Lu C-W, Chiu S-N, Chen C-A, et al. Losartan added to β-Blockade therapy for aortic Root Dilation in Marfan Syndrome: a randomized, open-label pilot study. Mayo Clin Proc. 2013;88:271–6.CrossRefPubMed
24.
Zurück zum Zitat Pees C, Laccone F, Hagl M, DeBrauwer V, Moser E, Michel-Behnke I. Usefulness of Losartan on the size of the Ascending Aorta in an unselected cohort of children, adolescents, and young adults with Marfan Syndrome. Am J Cardiol. 2013;112:1477–83.CrossRefPubMed Pees C, Laccone F, Hagl M, DeBrauwer V, Moser E, Michel-Behnke I. Usefulness of Losartan on the size of the Ascending Aorta in an unselected cohort of children, adolescents, and young adults with Marfan Syndrome. Am J Cardiol. 2013;112:1477–83.CrossRefPubMed
25.
Zurück zum Zitat Yetman AT, Bornemeier RA, McCrindle BW. Usefulness of Enalapril Versus Propranolol or Atenolol for Prevention of aortic dilation in patients with the Marfan Syndrome. Am J Cardiol. 2005;95:1125–7.CrossRefPubMed Yetman AT, Bornemeier RA, McCrindle BW. Usefulness of Enalapril Versus Propranolol or Atenolol for Prevention of aortic dilation in patients with the Marfan Syndrome. Am J Cardiol. 2005;95:1125–7.CrossRefPubMed
26.
Zurück zum Zitat Parida SK, Kriss VM, Hall BD. Hiatus/paraesophageal hernias in neonatal Marfan syndrome. Am J Med Genet. 1997;72:156–8.CrossRefPubMed Parida SK, Kriss VM, Hall BD. Hiatus/paraesophageal hernias in neonatal Marfan syndrome. Am J Med Genet. 1997;72:156–8.CrossRefPubMed
27.
Zurück zum Zitat Jacobs AM, Toudjarska I, Racine A, Tsipouras P, Kilpatrick MW, Shanske A. A recurring FBN1 gene mutation in neonatal Marfan Syndrome. Arch Pediatr Adolesc Med. 2002;156:1081.CrossRefPubMed Jacobs AM, Toudjarska I, Racine A, Tsipouras P, Kilpatrick MW, Shanske A. A recurring FBN1 gene mutation in neonatal Marfan Syndrome. Arch Pediatr Adolesc Med. 2002;156:1081.CrossRefPubMed
28.
Zurück zum Zitat Petersons A, Liepina M, Spitz L. Neonatal intrathoracic stomach in Marfan’s syndrome: report of two cases. J Pediatr Surg. 2003;38:1663–4.CrossRefPubMed Petersons A, Liepina M, Spitz L. Neonatal intrathoracic stomach in Marfan’s syndrome: report of two cases. J Pediatr Surg. 2003;38:1663–4.CrossRefPubMed
29.
Zurück zum Zitat Al-Assiri A, Wiseman N, Bunge M. Prenatal diagnosis of intrathoracic stomach (gastric herniation). J Pediatr Surg. 2005;40:E15–7.CrossRefPubMed Al-Assiri A, Wiseman N, Bunge M. Prenatal diagnosis of intrathoracic stomach (gastric herniation). J Pediatr Surg. 2005;40:E15–7.CrossRefPubMed
31.
Zurück zum Zitat Keswani RN, Prachand VN, Te HS. Paraesophageal hernia: a rare presentation of Marfan syndrome in adults. Gastrointest Endosc. 2007;66:1050–2.CrossRefPubMed Keswani RN, Prachand VN, Te HS. Paraesophageal hernia: a rare presentation of Marfan syndrome in adults. Gastrointest Endosc. 2007;66:1050–2.CrossRefPubMed
32.
Zurück zum Zitat Jetley NK, Al-Assiri AH, Awadi DA. Congenital para esophageal hernia: a 10 year experience from Saudi Arabia. Indian J Pediatr. 2009;76:489–93.CrossRefPubMed Jetley NK, Al-Assiri AH, Awadi DA. Congenital para esophageal hernia: a 10 year experience from Saudi Arabia. Indian J Pediatr. 2009;76:489–93.CrossRefPubMed
33.
Zurück zum Zitat Herman TE, Siegel MJ, Mathur A, Vachharajani A. Neonatal marfan syndrome with hiatus hernia and intrathoracic stomach. J Perinatol. 2013;33:652–3.CrossRefPubMed Herman TE, Siegel MJ, Mathur A, Vachharajani A. Neonatal marfan syndrome with hiatus hernia and intrathoracic stomach. J Perinatol. 2013;33:652–3.CrossRefPubMed
34.
Zurück zum Zitat Thakur S, Jhobta A, Sharma B, Chauhan A, Thakur CS. Unusual presentation of adult Marfan syndrome as a complex diaphragmatic hiatus hernia. Asian J Surg. 2017;40:313–6.CrossRefPubMed Thakur S, Jhobta A, Sharma B, Chauhan A, Thakur CS. Unusual presentation of adult Marfan syndrome as a complex diaphragmatic hiatus hernia. Asian J Surg. 2017;40:313–6.CrossRefPubMed
35.
Zurück zum Zitat Stępiński P, Stankowski T, Aboul-Hassan SS, Szymańska A, Marczak J, Cichoń R. Combined mitral valve replacement associated with the Bentall procedure, diaphragmatic hernia repair and reconstruction of the pectus excavatum in a 26-year-old patient with Marfan syndrome. Kitp. 2016;2:135–9.CrossRef Stępiński P, Stankowski T, Aboul-Hassan SS, Szymańska A, Marczak J, Cichoń R. Combined mitral valve replacement associated with the Bentall procedure, diaphragmatic hernia repair and reconstruction of the pectus excavatum in a 26-year-old patient with Marfan syndrome. Kitp. 2016;2:135–9.CrossRef
36.
Zurück zum Zitat Kothari J, Hinduja M, Baria K, Pandya H. Ascending aortic aneurysm and diaphragmatic hernia in a case of Marfan syndrome. Asian Cardiovasc Thorac Ann. 2017;25:378–80.CrossRefPubMed Kothari J, Hinduja M, Baria K, Pandya H. Ascending aortic aneurysm and diaphragmatic hernia in a case of Marfan syndrome. Asian Cardiovasc Thorac Ann. 2017;25:378–80.CrossRefPubMed
37.
Zurück zum Zitat Gupta A, Zia B, Mullassery D, De Coppi P, Giuliani S, Curry JI, et al. Congenital intrathoracic stomach can be safely managed laparoscopically. Pediatr Surg Int. 2020;36:165–9.CrossRefPubMed Gupta A, Zia B, Mullassery D, De Coppi P, Giuliani S, Curry JI, et al. Congenital intrathoracic stomach can be safely managed laparoscopically. Pediatr Surg Int. 2020;36:165–9.CrossRefPubMed
38.
Metadaten
Titel
Multidisciplinary follow-up in a patient with Morgagni hernia leads to diagnosis of Marfan syndrome
verfasst von
Ester Capecchi
Roberta Villa
Alessandro Pini
Maria Iascone
Laura Messina
Paola Francesca Ajmone
Fabio Mosca
Silvana Gangi
Maria Francesca Bedeschi
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
Italian Journal of Pediatrics / Ausgabe 1/2024
Elektronische ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-024-01643-8

Weitere Artikel der Ausgabe 1/2024

Italian Journal of Pediatrics 1/2024 Zur Ausgabe

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.